News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
700,204 Results
Type
Article (39799)
Company Profile (249)
Press Release (660156)
Multimedia
Podcasts (51)
Webinars (12)
Section
Business (204233)
Career Advice (2010)
Deals (35432)
Drug Delivery (95)
Drug Development (81054)
Employer Resources (173)
FDA (16191)
Job Trends (14869)
News (345290)
Policy (32565)
Tag
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (86)
Alliances (49459)
ALS (95)
Alzheimer's disease (1384)
Antibody-drug conjugate (ADC) (132)
Approvals (16189)
Artificial intelligence (265)
Autoimmune disease (22)
Automation (17)
Bankruptcy (360)
Best Places to Work (11638)
BIOSECURE Act (20)
Biosimilars (106)
Biotechnology (177)
Bladder cancer (79)
Brain cancer (27)
Breast cancer (292)
Cancer (2321)
Cardiovascular disease (179)
Career advice (1679)
Career pathing (30)
CAR-T (155)
Cell therapy (438)
Cervical cancer (20)
Clinical research (66093)
Collaboration (857)
Company closure (2)
Compensation (569)
Complete response letters (19)
COVID-19 (2590)
CRISPR (41)
C-suite (251)
Cystic fibrosis (102)
Data (2337)
Decentralized trials (2)
Denatured (19)
Depression (44)
Diabetes (275)
Diagnostics (6391)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (105)
Drug shortages (25)
Duchenne muscular dystrophy (97)
Earnings (87072)
Editorial (40)
Employer branding (22)
Employer resources (147)
Events (112669)
Executive appointments (743)
FDA (17572)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (773)
Gene editing (109)
Generative AI (20)
Gene therapy (314)
GLP-1 (720)
Government (4438)
Grass and pollen (4)
Guidances (162)
Healthcare (18823)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (29)
Infectious disease (2735)
Inflammatory bowel disease (143)
Inflation Reduction Act (9)
Influenza (52)
Intellectual property (98)
Interviews (312)
IPO (16530)
IRA (40)
Job creations (3636)
Job search strategy (1424)
Kidney cancer (10)
Labor market (43)
Layoffs (476)
Leadership (17)
Legal (7916)
Liver cancer (76)
Lung cancer (325)
Lymphoma (157)
Machine learning (9)
Management (58)
Manufacturing (330)
MASH (77)
Medical device (13386)
Medtech (13391)
Mergers & acquisitions (19478)
Metabolic disorders (708)
Multiple sclerosis (83)
NASH (16)
Neurodegenerative disease (94)
Neuropsychiatric disorders (27)
Neuroscience (1943)
NextGen: Class of 2025 (6518)
Non-profit (4480)
Now hiring (40)
Obesity (371)
Opinion (206)
Ovarian cancer (81)
Pain (91)
Pancreatic cancer (88)
Parkinson's disease (154)
Partnered (22)
Patents (245)
Patient recruitment (116)
Peanut (46)
People (57362)
Pharmaceutical (63)
Pharmacy benefit managers (20)
Phase I (20593)
Phase II (29111)
Phase III (21677)
Pipeline (1385)
Policy (148)
Postmarket research (2563)
Preclinical (8761)
Press Release (64)
Prostate cancer (108)
Psychedelics (30)
Radiopharmaceuticals (247)
Rare diseases (385)
Real estate (5910)
Recruiting (66)
Regulatory (22339)
Reports (48)
Research institute (2323)
Resumes & cover letters (349)
Rett syndrome (6)
RNA editing (5)
RSV (42)
Schizophrenia (72)
Series A (132)
Series B (91)
Service/supplier (11)
Sickle cell disease (52)
Special edition (16)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3584)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (51)
The Weekly (30)
Vaccines (699)
Venture capitalists (42)
Weight loss (237)
Women's health (36)
Worklife (16)
Date
Today (115)
Last 7 days (962)
Last 30 days (3214)
Last 365 days (32472)
2025 (11948)
2024 (35224)
2023 (40091)
2022 (51181)
2021 (55716)
2020 (54096)
2019 (46546)
2018 (35027)
2017 (32143)
2016 (31497)
2015 (37560)
2014 (31322)
2013 (26349)
2012 (28577)
2011 (29266)
2010 (27331)
Location
Africa (719)
Alabama (54)
Alaska (7)
Arizona (233)
Arkansas (13)
Asia (37908)
Australia (6194)
California (6428)
Canada (2068)
China (540)
Colorado (274)
Connecticut (281)
Delaware (158)
Europe (81442)
Florida (957)
Georgia (216)
Idaho (57)
Illinois (547)
India (25)
Indiana (323)
Iowa (11)
Japan (173)
Kansas (106)
Kentucky (24)
Louisiana (11)
Maine (62)
Maryland (922)
Massachusetts (4776)
Michigan (226)
Minnesota (405)
Mississippi (2)
Missouri (82)
Montana (27)
Nebraska (25)
Nevada (68)
New Hampshire (63)
New Jersey (1798)
New Mexico (28)
New York (1809)
North Carolina (992)
North Dakota (8)
Northern California (2837)
Ohio (210)
Oklahoma (14)
Oregon (34)
Pennsylvania (1430)
Puerto Rico (13)
Rhode Island (33)
South America (1098)
South Carolina (26)
South Dakota (1)
Southern California (2414)
Tennessee (106)
Texas (951)
United States (24069)
Utah (188)
Virginia (152)
Washington D.C. (64)
Washington State (566)
West Virginia (3)
Wisconsin (56)
700,204 Results for "illumina inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Illumina completes the divestiture of GRAIL
Illumina, Inc. announced the successful completion of the spin-off of GRAIL. This milestone follows the company’s previously announced plans to divest GRAIL, and GRAIL is now a public and independent company.
June 24, 2024
·
6 min read
Biotech Beach
Illumina To Webcast Upcoming May 2024 Investor Conference
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 15, 2024
·
1 min read
Biotech Beach
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc., a global leader in DNA sequencing and array-based technologies, published its fifth annual Corporate Social Responsibility Report.
May 28, 2024
·
4 min read
Business
Illumina appoints Everett Cunningham Chief Commercial Officer
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the appointment of Everett Cunningham as Chief Commercial Officer, effective June 10.
June 3, 2024
·
2 min read
Biotech Beach
Illumina To Webcast Upcoming Investor Conference - May 03, 2024
Illumina, Inc. announced that its executives will be speaking at the following investor conference.
May 3, 2024
·
1 min read
Business
Illumina Lays Out Growth Roadmap After Grail Divestment
In a bid to win back investor confidence, Illumina on Tuesday unveiled a three-year growth plan focused on easier DNA sequencing and improved data analysis for customers.
August 14, 2024
·
2 min read
·
Tristan Manalac
Business
Illumina Reports Financial Results for First Quarter of Fiscal Year 2024
Illumina, Inc. (Nasdaq: ILMN) (“Illumina” or the “company”) today announced its financial results for the first quarter of fiscal year 2024, which include the consolidated financial results for GRAIL.
May 2, 2024
·
24 min read
Biotech Beach
Illumina Board of Directors approves spin-off of GRAIL; declares spin-off dividend of GRAIL shares
Illumina, Inc. announced that its Board of Directors has approved the spin-off of GRAIL.
June 3, 2024
·
6 min read
Biotech Beach
Illumina DRAGEN v4.3 powers most comprehensive, accurate genome with industry-leading innovations
Illumina Inc., a global leader in DNA sequencing and array-based technologies, announced the launch of DRAGEN™ v4.3, the latest version of its DRAGEN™ software, part of the Illumina Connected Software portfolio, for analysis of next-generation sequencing data.
June 11, 2024
·
5 min read
Press Releases
Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2
November 21, 2024
·
4 min read
1 of 70,021
Next
